Data / Form D filings / Dosentrx Ltd.
Dosentrx Ltd.: Form D filing
Dosentrx Ltd., a pharmaceuticals company in Modiin Maccabim Reut, Israel, filed a Form D with the SEC in 2026. The latest, on March 19, 2026, reports $1.8 million sold of a $6 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 HAMAAYAN ST, Modiin Maccabim Reut, Israel, 71778
- Phone
- 972 52-2890796
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2121365
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | New notice | $6,000,000 | $1,780,000 | $4,220,000 | 17 | Feb 18, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Summers | Executive Officer | |
| Jon Roberts | Director | |
| Daniel Beck | Director | |
| Gerald Lieberman | Director | |
| Alan Paz | Executive Officer, Director | |
| Frank Sheehy | Director | |
| Liron Levi-Gabay | Executive Officer | General Counsel |
Every Form D from the week of Mar 16, 2026 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Dosentrx Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.